NRXN1
NRXN1 (neurexin 1) is a neuronal cell-surface protein of the neurexin family that mediates cell recognition and adhesion by binding neuroligins at synapses. It is also known as KIAA0578, and the UniProt entry is named Neurexin-1-beta. Browse Assay Genie's current range of NRXN1 research reagents below, or read on for the biology behind the target.
NRXN1 is a neuronal cell-surface protein involved in cell recognition and cell adhesion. It forms intracellular junctions by binding to neuroligins, and it plays a role in the formation of synaptic junctions. Neurexins act as cell-surface receptors that bind neuroligins to form Ca(2+)-dependent neurexin/neuroligin complexes at synapses in the central nervous system. This complex is required for efficient neurotransmission and is involved in the formation of synaptic contacts.
NRXN1 also works as part of a trans-synaptic complex by binding to cerebellins and to postsynaptic GRID1. This interaction helps regulate the activity of NMDA and AMPA receptors at hippocampal synapses without affecting synapse formation. The NRXN1B-CBLN2-GRID1 complex transduces presynaptic signals into postsynaptic NMDAR responses. The protein localises to the presynaptic cell membrane.
The NRXN1 gene encodes a single-pass type I membrane protein. Three neurexin family members have been studied in detail, and together they are estimated to generate over 3,000 variants through two alternative promoters (alpha and beta) and extensive alternative splicing in each member. A third promoter (gamma) was identified more recently in the 3' region of this gene. Mutations in NRXN1 are associated with Pitt-Hopkins-like syndrome-2 and may contribute to susceptibility to schizophrenia. HGNC places the gene in the neurexin group, and it also lists it as a microRNA protein coding host gene.
NRXN1 binds neuroligins and takes part in forming synaptic junctions and contacts, making it a core target for studying synaptic adhesion.
Neurexin/neuroligin complexes are required for efficient neurotransmission in the central nervous system.
Through cerebellins and GRID1, NRXN1 helps regulate NMDA and AMPA receptor activity at hippocampal synapses.
Mutations in NRXN1 are linked to Pitt-Hopkins-like syndrome-2 and may contribute to schizophrenia susceptibility.
NRXN1 is a presynaptic cell-surface protein that binds neuroligins to mediate cell recognition and adhesion and to support synaptic junction formation. It also binds cerebellins and postsynaptic GRID1, helping regulate NMDA and AMPA receptor activity at hippocampal synapses.
Neurexin genes use two alternative promoters, alpha and beta, plus extensive alternative splicing, and the family is estimated to generate over 3,000 variants. A third gamma promoter has also been identified for NRXN1. The UniProt entry here is named Neurexin-1-beta; KIAA0578 is an alias.
Mutations in NRXN1 are associated with Pitt-Hopkins-like syndrome-2 and may contribute to susceptibility to schizophrenia. Orthologues exist in mouse and rat, both named Nrxn1; check the datasheet of any product for its validated reactivity.
Other neurexin family members that act at synapses in the central nervous system.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P58400; product specifications from Assay Genie datasheets.